Search for: "Astrazeneca" Results 441 - 460 of 1,244
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Sep 2014, 6:11 am by Paul Caron
Wall Street Journal, AstraZeneca Called the Obama Team to Say: Stop Those Tax Inversions!! [read post]
4 Sep 2014, 1:00 am
It is also not clear on first reading whether AstraZeneca fought the inclusion of these articles in the CGK, and if so, what the competing arguments were or why Teva’s arguments were preferred. [read post]
25 Aug 2014, 2:21 pm
Clare Young, on the Allens' Scintilla IP weblog, reports on some fascinating litigation in Australia between AstraZeneca and Apotex over obviousness as the 'starting point' for assessing a patent's validity. [read post]
16 Aug 2014, 11:39 pm by Mark Summerfield
AstraZeneca AB v Apotex Pty Ltd [2014] FCAFC 99 (12 August 2014)An expanded panel of five judges of the Federal Court of Australia has held that two patents owned by AstraZeneca relating to the cholesterol-lowering drug marketed as CRESTOR (active ingredient rosuvastatin) are invalid. [read post]
31 Jul 2014, 12:00 am
While the proposed change would be successful in stopping mergers such as Abbvie/Shire, where the Shire shareholders would only own approximately 25 percent of the combined company, it potentially could actually encourage deals like AstraZeneca/Pfizer, which are much closer in size. [read post]
27 Jul 2014, 5:07 pm by INFORRM
On 22 July 2014, HHJ Moloney QC heard an application in the harassment case of AstraZeneca UK Ltd & anr v Mathai & ors. [read post]
30 Jun 2014, 4:23 am by Lawrence B. Ebert
Quoting emails from Harold Wegner, Gigom suggests that Philip Johnson of Johnson & Johnson is in line for the Director position at the US Patent Office.The Gigaom post included the text:In December, Johnson testified before the Senate on behalf of the 21st Century Patent Coalition, a group of companies who opposed a bill that would have made it easier for defendants to challenge low-quality patents, and to recover legal costs in the face of frivolous patent lawsuits.Members of the Patent… [read post]
24 Jun 2014, 7:22 pm by Jon Gelman
Harry Lever, a cardiologist at the Cleveland Clinic, has been warning nearly anyone who would listen of his growing suspicions about generic versions of a widely used heart drug, Toprol XL.Patient after patient, he said, would visit his office complaining of chest pains or other symptoms after switching from the brand-name version, made by AstraZeneca, to a generic product, often one made in India. [read post]
23 Jun 2014, 12:57 pm by Schachtman
ITERATIVE DISJUNCTIVE SYLLOGISM Basic propositional logic teaches that the disjunctive syllogism (modus tollendo ponens) is a valid argument, in which one of its premises is a disjunction (P v Q), and the other premise is the negation of one of the disjuncts: P v Q ~P­­­_____ ∴ Q See Irving Copi & Carl Cohen Introduction to Logic at 362 (2005). [read post]
22 Jun 2014, 9:01 pm by Ronald D. Rotunda
Recently, the news reported that Pfizer, Inc. wants to buy a British rival, AstraZeneca, PLC for nearly $100 billion. [read post]
15 Jun 2014, 10:36 am by Schachtman
AstraZeneca Pharms., 602 F.3d 1245, 1255 (11th Cir. 2010) (“An expert, however, cannot merely conclude that all risk factors for a disease are substantial contributing factors in its development. [read post]
14 Jun 2014, 1:47 pm by Paul Caron
Last month Pfizer attempted to acquire AstraZeneca, a transaction... [read post]
2 Jun 2014, 9:14 am by Charles Nathan, RLM Finsbury,
What distinguishes the Valeant/Pershing deal from a conventional public bear hug (such as Pfizer’s recent effort to acquire AstraZeneca) is that, by pre-arrangement, Pershing Square acquired a 9.7% equity stake in Allergan immediately prior to the first public announcement of Valeant’s bear hug. [read post]
26 May 2014, 12:00 am by Kingsley Egbuonu
This news reminds this Leo of Pfizer's recent takeover bid for AstraZeneca - which commentators mention the UK's Patent Box regime as one of the factors behind the bid. [read post]
22 May 2014, 4:49 am by Vickie Nijjar
Some people, including the AstraZeneca shareholders, may be wondering why the Board effectively prevented the shareholders from taking Pfizer’s offer that would produce £55 a share. [read post]
22 May 2014, 4:49 am by Vickie Nijjar
Some people, including the AstraZeneca shareholders, may be wondering why the Board effectively prevented the shareholders from taking Pfizer’s offer that would produce £55 a share. [read post]
21 May 2014, 12:40 pm by Charles (Chuck) Rubin
This is the story behind Pfizer’s attempt to acquire U.K pharmaceutical company AstraZeneca. [read post]
20 May 2014, 6:43 am by Pete Strom
Generic Blood Pressure Medication Under Drug Recall Another generic pharmaceutical manufacturer based in India has issued a large drug recall, this time for Metoprolol, a generic form of AstraZeneca’s branded anti-hypertensive medication, Toprol. [read post]
16 May 2014, 6:35 am
CanadaCanada set to bring in new rules for businesses wanting to hire temporary foreign workers, ReutersCompetition watchdog wants steps taken to 'dampen' wholesale wireless roaming rates, ReutersExperts say young girl's decision to forego chemo, treat cancer with indigenous medicine may be legal, The National PostUnited StatesAmid protests, regulators push forward with net neutrality rules, Reuters'At least 10 members' of non-profit Bitcoin Foundation resigned over new… [read post]